The European Hematology Association (EHA)

Research

Publications

In this section, this SWG wants to provide a broad list of practical recommendations for the diagnosis and management of AML. This list will be updated on a regular basis.

  1. European LeukemiaNet recommendation for the management of AML in adults (2017): https://ashpublications.org/blood/article-pdf/129/4/424/1402046/blood733196.pdf
  2. European LeukemiaNet recommendation for the management of APL (2019): https://ashpublications.org/blood/article-pdf/133/15/1630/1553020/blood894980.pdf
  3. European Society for Medical Oncology guidelines for the management of AML in adults (2020): https://www.annalsofoncology.org/article/S0923-7534(20)36079-8/pdf
  4. British Society of Haematology guidelines for the management of AML in pregnancy (2015): https://onlinelibrary.wiley.com/doi/epdf/10.1111/bjh.13554
  5. American Society of Hematology guidelines for the management of AML in older adults (2020): https://ashpublications.org/bloodadvances/article-pdf/4/15/3528/1751528/advancesadv2020001920c.pdf
  6. National Comprehensive Cancer Network guidelines for the management of AML and APL (2021) (requires free registration): https://www.nccn.org/professionals/physician_gls/pdf/aml.pdf
  7. European LeukemiaNet recommendation for minimal residual disease monitoring in AML (2021): https://ashpublications.org/blood/article-pdf/doi/10.1182/blood.2021013626/1832241/blood.2021013626.pdf
  8. Annual clinical updates on AML; American Journal of Hematology by Elihu Estey (2021): https://onlinelibrary.wiley.com/doi/epdf/10.1002/ajh.25975

Guidelines:

  • Heuser M, Freeman SD, Ossenkoppele GJ, Buccisano F, Hourigan CS, Ngai LL, Tettero JM, Bachas C, Baer C, Béné MC, Buecklein V, Czyz A, Denys B, Dillon R, Feuring-Buske M, Guzman ML, Haferlach T, Han L, Herzig JK, Jorgensen JL, Kern W, Konopleva MY, Lacombe F, Libura M, Majchrzak A, Maurillo L, Ofran Y, Philippé J, Plesa A, Preudhomme C, Ravandi F, Roumier C, Subklewe M, Thol F, van de Loosdrecht AA, van der Reijden BA, Venditti A, Wierzbowska A, Valk PJM, Wood BL, Walter RB, Thiede C, Döhner K, Roboz GJ, Cloos J. 2021 Update Measurable Residual Disease in Acute Myeloid Leukemia: European LeukemiaNet Working Party Consensus Document. 2021 Dec 30;138(26):2753-2767.
  • Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka HM, Wang SA, Bagg A, Barbui T, Branford S, Bueso-Ramos CE, Cortes JE, Dal Cin P, DiNardo CD, Dombret H, Duncavage EJ, Ebert BL, Estey EH, Facchetti F, Foucar K, Gangat N, Gianelli U, Godley LA, Gökbuget N, Gotlib J, Hellström-Lindberg E, Hobbs GS, Hoffman R, Jabbour EJ, Kiladjian JJ, Larson RA, Le Beau MM, Loh ML, Löwenberg B, Macintyre E, Malcovati L, Mullighan CG, Niemeyer C, Odenike OM, Ogawa S, Orfao A, Papaemmanuil E, Passamonti F, Porkka K, Pui CH, Radich JP, Reiter A, Rozman M, Rudelius M, Savona MR, Schiffer CA, Schmitt-Graeff A, Shimamura A, Sierra J, Stock WA, Stone RM, Tallman MS, Thiele J, Tien HF, Tzankov A, Vannucchi AM, Vyas P, Wei AH, Weinberg OK, Wierzbowska A, Cazzola M, Döhner H, Tefferi A. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. 2022 Sep 15;140(11):1200-1228
  • Döhner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, Ebert BL, Fenaux P, Godley LA, Hasserjian RP, Larson RA, Levine RL, Miyazaki Y, Niederwieser D, Ossenkoppele G, Röllig C, Sierra J, Stein EM, Tallman MS, Tien HF, Wang J, Wierzbowska A, Löwenberg B. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. 2022 Sep 22;140(12):1345-1377.

Original scientific publications

  • Döhner H, Malcovati L, Ossenkoppele GJ, Hochhaus A, Maria Vannucchi A, Bullinger L, Cervantes F, Craddock C, de Witte T, Döhner K, Dombret H, Fenaux P, Geissler J, Germing U, Guilhot F, Harrison C, Hellström-Lindberg E, Passamonti F, Sierra J, Skoda R, Wierzbowska A. The EHA Research Roadmap: Malignant Myeloid Diseases. Hemasphere. 2021;5(9):e635